logo
15:54 Dec 05

Nectar Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
20.95
+0.01 (+0.05%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Nectar Lifesciences Ltd. Financials

Nectar Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
20.95
+0.01 (+0.05%)
15:54 Dec 05
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

46/100
Mid Valuation

Technical

52/100
Technically Neutral

Strength

5

Weakness

8

Opportunity

0

Threats

0

-11.88 %

ROE %

-5.55 %

ROA %

-16.12

EPS

42.63

BVPS

-6.80 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1668.83 1523.67 1684.09 1669.97 1171.34
Operating Expenses +
1510.29 1470.66 1532.53 1699.53 1343.86
Raw Material
1207.32 1200.84 1242.45 1250.72 939.33
Increase Decrease in Cost
15.81 -41.55 -40.21 117.29 162.18
Other Manufacturing Expense
146.37 172.14 184.64 163.22 0
Employee Cost
74.55 77.78 84.67 96.48 73.32
Miscellaneous Expenses
67.12 61.45 60.98 71.82 169.03
Operating Profit
158.54 53.01 151.56 -29.56 -172.52
Other Income
11.32 43.18 14.58 4.99 1.74
Depreciation
56.97 59.12 60.72 62.39 48.1
Interest
78.81 79.49 87.14 74.58 53.49
Profit before tax and exceptio..
34.08 -42.42 18.27 -161.53 -272.37
Exceptional Items
0 0 0 0 0
PBT
34.08 -42.42 18.27 -161.53 -272.37
Provision for Taxation
9.03 -18.24 13.27 -47.85 -86.57
Net Profit
25.05 -24.18 5 -113.68 -361.49
NET Profit after MI
25.05 -24.18 5 -113.68 -361.49
EPS
1.12 -1.08 0.22 -5.07 -16.11
Operating Profit Margin (%)
9.5 3.48 9 -1.77 -14.73
Net Profit Margin (%)
1.5 -1.59 0.3 -6.81 -30.86

Nectar Lifesciences Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 44.90 44.50 44.50 44.50 55.80 55.80
FII 0.60 0.80 1.60 0.70 3.20 16.60
Public 0.10 0.20 0.20 0.10 0.10 0.00
Others 54.40 54.50 53.70 54.70 40.90 27.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: